Literature DB >> 26137014

Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report.

Takeshi Matsumoto1, Yukihiro Imai2, Yasuhiro Kosaka3, Takashi Shintani3, Keisuke Tomii1.   

Abstract

In the present study, a 79-year-old male was referred to Kobe City Medical Center General Hospital due to an abnormal shadow that was revealed on a chest X-ray. The patient possessed a five-year history of consolidation in the right lower lobe, which was diagnosed as chronic aspiration pneumonia and followed up. However, the abnormal shadow adjacent to the pleura gradually increased in size and a novel mass appeared in the right lower lobe that rapidly increased in size. A repeat biopsy revealed a combination of large cell neuroendocrine carcinoma with a clinical tumor-node-metastasis (cTNM) stage of cT2bN2M0 (stage 3A) and mucosa-associated lymphoid tissue lymphoma at Ann Arbor stage 1E. Chemoradiotherapy markedly affected the lesion and the size of the mass was significantly reduced subsequent to four cycles of chemotherapy, which was considered to be a near complete response. The present study reports an extremely rare combination of tumors. The disease course was followed over a period of six years, which included the onset of disease, and the present case may therefore be valuable in clarifying the mechanism of lung cancer development.

Entities:  

Keywords:  chemoradiotherapy; large cell neuroendocrine carcinoma; mix; mucosa-associated lymphoid tissue lymphoma

Year:  2015        PMID: 26137014      PMCID: PMC4467299          DOI: 10.3892/ol.2015.2994

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Primary tracheal mucosa-associated lymphoid tissue lymphoma accompanying lung cancer. Common tumorigenesis or coincidental coexistence?

Authors:  T Suzuki; T Akizawa; H Suzuki; K Kitazume; M Omine; T Mitsuya
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-12

2.  Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yasumitsu Moriya; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Yukio Nakatani; Takehiko Fujisawa
Journal:  J Thorac Cardiovasc Surg       Date:  2006-08       Impact factor: 5.209

3.  Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.

Authors:  Sung Yong Oh; Won Seog Kim; Jin Seok Kim; Seok Jin Kim; Hyuk-Chan Kwon; Dae Ho Lee; Jong Ho Won; In Gyu Hwang; Min Kyoung Kim; Soon Il Lee; Yee Soo Chae; Deok-Hwan Yang; Gyeong-Won Lee; Chul Won Choi; Jinny Park; Cheolwon Suh; Hyo-Jin Kim
Journal:  Ann Hematol       Date:  2009-12-19       Impact factor: 3.673

4.  Concurrent lung squamous cell carcinoma and extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type.

Authors:  Muhammad Adrish; Sindhaghatta Venkatram; Masooma Niazi; Gilda Diaz-Fuentes
Journal:  J Bronchology Interv Pulmonol       Date:  2014-01

5.  Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.

Authors:  A Iyoda; K Hiroshima; T Toyozaki; Y Haga; T Fujisawa; H Ohwada
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

6.  Synchronous pulmonary adenocarcinoma and extranodal marginal zone/low-grade B-cell lymphoma of MALT type.

Authors:  S Chanel; L Burke; M Fiche; T Molina; J P Lerochais; P Icard; J Diebold; F Galateau-Sallé
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

7.  Non-Hodgkin's lymphoma and type of tobacco smoke.

Authors:  Emanuele Stagnaro; Rosario Tumino; Stefano Parodi; Paolo Crosignani; Arabella Fontana; Giovanna Masala; Lucia Miligi; Oriana Nanni; Valerio Ramazzotti; Stefania Rodella; Adele Senoiri Constantini; Clotilde Vigano; Carla Vindigni; Paolo Vineis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

Review 8.  Primary pulmonary lymphoma.

Authors:  J Cadranel; M Wislez; M Antoine
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

9.  A Case of Synchronous Lung Adenocarcinoma and Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type.

Authors:  Chi Young Jung; Kun Young Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

10.  Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?

Authors:  T Tihan; D A Filippa
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.